Vaniprevir
Vaniprevir (pronunciation: va-ni-pre-vir) is a protease inhibitor used in the treatment of Hepatitis C. It is a second-generation protease inhibitor developed by Merck & Co..
Etymology
The name "Vaniprevir" is derived from the Latin word "vani" meaning empty and "previr" meaning before man, signifying its role in emptying the body of the Hepatitis C virus before it can cause significant harm.
Usage
Vaniprevir is used in combination with other antiviral medications to treat chronic (long-lasting) Hepatitis C, a viral infection that can damage the liver over time. This medication works by reducing the amount of Hepatitis C virus in your body, which may help your liver recover.
Mechanism of Action
Vaniprevir works by inhibiting the NS3/4A protease, an enzyme that the Hepatitis C virus requires for replication. By blocking this enzyme, Vaniprevir prevents the virus from multiplying and can reduce the amount of virus in the body.
Related Terms
See Also
External links
- Medical encyclopedia article on Vaniprevir
- Wikipedia's article - Vaniprevir
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski